Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency

Blood

Volumn 119, Issue 23, 2012, Pages 5458-5466

  Kawai, Tomoki ^a   Nishikomori, Ryuta ^a   Izawa, Kazushi ^a   Murata, Yuuki ^a   Tanaka, Naoko ^a   Sakai, Hidemasa ^a   Saito, Megumu ^b   Yasumi, Takahiro ^a   Takaoka, Yuki ^a   Nakahata, Tatsutoshi ^b   Mizukami, Tomoyuki ^c   Nunoi, Hiroyuki ^c   Kiyohara, Yuki ^d   Yoden, Atsushi ^e   Murata, Takuji ^e   Sasaki, Shinya ^f   Ito, Etsuro ^f   Akutagawa, Hiroshi ^g   Kawai, Toshinao ^h   Imai, Chihaya ⁱ   Okada, Satoshi ^j   Kobayashi, Masao ^j   Heike, Toshio ^a   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g Kishiwada City Hospital   (Japan)

^h NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

ⁱ NIIGATA UNIVERSITY   (Japan)

^j HIROSHIMA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CYCLOSPORIN A; ETHAMBUTOL; FLUDARABINE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; RIFABUTIN; SULFAMETHOXAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM;

APPETITE; ARTICLE; ASPERGILLOSIS; ATYPICAL MYCOBACTERIOSIS; BASE MISPAIRING; BODY WEIGHT; BRAIN DISEASE; CD3+ T LYMPHOCYTE; CHILD; CHIMERA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAILURE TO THRIVE; GENE DUPLICATION; GENE EXPRESSION; GENE FREQUENCY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HYPOHIDROTIC ECTODERMAL DYSPLASIA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INFECTION PREVENTION; INFECTION SENSITIVITY; JAPAN; LYMPHOCYTE PROLIFERATION; MOSAICISM; MYCOBACTERIOSIS; MYCOBACTERIUM SZULGAI; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPTIC SHOCK; SOMATIC MOSAICISM; SOMATIC MUTATION; WEIGHT GAIN; X CHROMOSOME LINKED DISORDER; X LINKED ANHIDROTIC ECTODERMAL DYSPLASIA WITH IMMUNODEFICIENCY;

EID: 84862563132     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-354167     Document Type: Article

References (38)

1. Pinheiro M, Freire-Maia N. Ectodermal dysplasias: a clinical classification and a causal review. Am J Med Genet. 1994;53(2):153-162. (Pubitemid 24335897)
2. Abinun M, Spickett G, Appleton AL, Flood T, Cant AJ. Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr. 1996;155(2):146-147. (Pubitemid 26043007)
3. Sitton JE, Reimund EL. Extramedullary hematopoiesis of the cranial dura and anhidrotic ectodermal dysplasia. Neuropediatrics. 1992;23(2):108-110.
4. Schweizer P, Kalhoff H, Horneff G, Wahn V, Diekmann L. [Polysaccharide specific humoral immunodeficiency in ectodermal dysplasia. Case report of a boy with two affected brothers]. Klin Padiatr. 1999;211(6):459-461.
5. Abinun M. Ectodermal dysplasia and immunodeficiency. Arch Dis Child. 1995;73(2):185.
6. Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67(6):1555-1562.
7. Courtois G, Smahi A, Israel A. NEMO/IKK gamma: linking NF-kappa B to human disease. Trends Mol Med. 2001;7(10):427-430. (Pubitemid 32964151)
8. Doffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27(3):277-285. (Pubitemid 32201848)
9. Rothwarf DM, Zandi E, Natoli G, Karin M. IKKgamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998;395(6699):297- 300. (Pubitemid 28447557)
10. Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93(7):1231-1240. (Pubitemid 28307427)
11. Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405(6785):466-472. (Pubitemid 30367424)
12. Hanson EP, Monaco-Shawver L, Solt LA, et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122(6):1169-1177.
13. Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol. 2004;113(4):725-733. (Pubitemid 38530430)
14. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2(3):223-228. (Pubitemid 33705998)
15. Orange JS, Brodeur SR, Jain A, et al. Deficient natural killer cell cytotoxicity in patients with IKKgamma/ NEMO mutations. J Clin Invest. 2002;109(11):1501-1509. (Pubitemid 34596176)
16. Sebban H, Courtois G. NF-kappaB and inflammation in genetic disease. Biochem Pharmacol. 2006;72(9):1153-1160.
17. Nishikomori R, Akutagawa H, Maruyama K, et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood. 2004;103(12):4565-4572. (Pubitemid 38745984)
18. Mizukami T, Obara M, Nishikomori R, et al. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J Clin Immunol. 2012;32(1):39-49.
19. Imamura M, Kawai T, Okada S, et al. Disseminated BCG infection mimicking metastatic nasopharyngeal carcinoma in an immunodeficient child with a novel hypomorphic NEMO mutation. J Clin Immunol. 2011;31(5):802-810.
20. Tono C, Takahashi Y, Terui K, et al. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen. Bone Marrow Transplant. 2007;39(12):801-804. (Pubitemid 46901979)
21. Saito M, Nishikomori R, Kambe N, et al. Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutationnegative cryopyrin-associated periodic syndrome patients. Blood. 2008;111(4):2132-2141. (Pubitemid 351451525)
22. Yang TP, Stout JT, Konecki DS, Patel PI, Alford RL, Caskey CT. Spontaneous reversion of novel Lesch- Nyhan mutation by HPRT gene rearrangement. Somat Cell Mol Genet. 1988;14(3):293-303.
23. Zhang LH, Jenssen D. Reversion of the hprt mutant clone SP5 by intrachromosomal recombination. Carcinogenesis. 1992;13(4):609-615.
24. Monnat RJ Jr, Chiaverotti TA, Hackmann AF, Maresh GA. Molecular structure and genetic stability of human hypoxanthine phosphoribosyltransferase (HPRT) gene duplications. Genomics. 1992;13(3):788-796.
25. Rautenstrauss B, Liehr T, Fuchs C, et al. Mosaicism for Charcot-Marie-Tooth disease type 1A: onset in childhood suggests somatic reversion in early developmental stages. Int J Mol Med. 1998;1(2):333-337.
26. Wada T, Candotti F. Somatic mosaicism in primary immune deficiencies. Curr Opin Allergy Clin Immunol. 2008;8(6):510-514.
27. Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol. 2001;166(8):5245-5249. (Pubitemid 32280741)
28. Stephan V, Wahn V, Le Deist F, et al. Atypical Xlinked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med. 1996;335(21):1563-1567. (Pubitemid 26384751)
29. Rieux-Laucat F, Hivroz C, Lim A, et al. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N Engl J Med. 2006;354(18):1913-1921. (Pubitemid 43872692)
30. Wada T, Toma T, Okamoto H, et al. Oligoclonal expansion of T lymphocytes with multiple secondsite mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood. 2005;106(6):2099-2101. (Pubitemid 41291725)
31. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J Med Genet. 2003;40(10):721-728. (Pubitemid 37311069)
32. Wada T, Schurman SH, Jagadeesh GJ, Garabedian EK, Nelson DL, Candotti F. Multiple patients with revertant mosaicism in a single Wiskott- Aldrich syndrome family. Blood. 2004;104(5):1270-1272. (Pubitemid 39166499)
33. Stewart DM, Candotti F, Nelson DL. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J Clin Immunol. 2007;27(6):634-639.
34. Davis BR, Yan Q, Bui JH, et al. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants. Clin Immunol. 2010;135(1):72-83.
35. Yamaoka S, Inoue H, Sakurai M, et al. Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 1996;15(4):873-887.
36. Speckmann C, Pannicke U, Wiech E, et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood. 2008;112(10):4090-4097.
37. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446(7135):557-561. (Pubitemid 46514732)
38. Fish JD, Duerst RE, Gelfand EW, Orange JS, Bunin N. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplant. 2009;43(3):217-221.